One Platform. Many Applications.
BioThera isolates and characterizes plant-derived extracellular vesicles at manufacturing scale. What those vesicles are formulated into is an application question, not a platform one. Below are the areas the platform is built to serve — and how far each one has actually gone.
Characterized material, documented batch by batch.
Material
Characterized EV bulk
Plant-derived extracellular vesicles isolated at manufacturing scale, counted by Nanoparticle Tracking Analysis and characterized against the MISEV2023 marker framework.
Documentation
Batch-specific CoA
Every batch ships with its own Certificate of Analysis: particle concentration, EV marker panel, and contamination screen. MISEV2023 disclosures available on request.
Logistics
Cold-chain delivery
Shipped directly from the BioThera Solutions facility in Ottawa, Ontario, in cold-chain packaging sized to the destination. No distributor handoff.
Where the platform applies — and how far it has gone.
Maturity reflects how far BioThera has taken each area, not what extracellular vesicles are claimed to do in the literature. Areas marked as research directions have no BioThera product and no published timeline.
Skincare & dermocosmetics
Topical formulation of characterized plant-derived EVs for professional skin care. Supplied to verified dermatology and aesthetic medicine clinics in Canada under our Vesera™ brand. Not in general distribution.
Clinical dermatology
An active safety and efficacy study is underway with practicing dermatologist partners. Clinics evaluating the material receive the batch-specific Certificate of Analysis behind every shipment.
Wound & barrier repair
EV cargo classes associated with wound healing appear in our proteomics data and in the plant-EV literature. We have characterization data; we do not yet have outcome data.
Regenerative medicine
The biomanufacturing and characterization requirements of regenerative applications are the ones this platform was engineered against. No BioThera product exists in this space.
Drug delivery
EVs are a phospholipid-bilayer delivery vehicle. Whether ours can carry an exogenous payload at specification is an open question we are equipped to answer.
Vesera™ — our dermocosmetic brand.
Vesera™ is BioThera’s dermocosmetic brand: plant-derived extracellular vesicles from Aloe barbadensis, formulated for professional skin care. It is a Health Canada-notified cosmetic, characterized to MISEV2023 on every batch. Vesera™ is one application of the platform — not the company.
Standards we manufacture to
Health Canada — 化粧品規制（C.R.C., c. 869）
カナダ消費者製品安全法（C.R.C., c. 869）に基づくカナダの化粧品規制に完全に準拠しています。カナダ市場承認済み。
MISEV2023 — 特性評価準拠
国際細胞外小胞学会（ISEV）が発行した細胞外小胞研究のための最小情報（MISEV2023）ガイドライン — グローバルスタンダードに完全に準拠しています。
Leaping Bunny動物実験反対認証
有効な認証。製造またはサプライチェーンのいかなる段階でも動物実験なし。
GMP/ISO準拠製造
ダーモコスメティックおよびEVベースのスキンケアポートフォリオを拡大するにつれ、GMPおよびISOへの整合に向けて積極的に開発中の製造プロセス。
FDA — FD&C Act / MoCRA準拠
連邦食品・醫薬品・化粧品法（FD&C Act, 21 U.S.C. § 361）および、2022年化粧品規制近代化法（MoCRA）に準拠した調剰です。米国市場への参入は将来のフェーズで計画されており——施設登録および完全なMoCRA遵守はその時点で取り組む予定です。
いち早くお知らせします。
ウェイトリストにご登録いただければ、Vesera™ Serumが入手可能になったときにお知らせします。また、あなたが誰なのかも知りたいと思います — 適切なアクセス経路を優先するのに役立ちます。
BioThera supplies cosmetic-grade material today. Vesera™ is a cosmetic under Health Canada Cosmetic Regulations and is not intended to diagnose, treat, cure, or prevent any disease. Application areas marked as research directions are not products, are not offered for sale, and carry no therapeutic claim.
Talk to us about supply or co-development.
Whether you need characterized EV material with documentation behind it, or want to explore an application that is not on this page, start with a conversation.
Contact the team